Summary by Futu AI
JUN SHENG TAI PHARMACEUTICAL-B (STOCK CODE: 2511.HK) RELEASED ITS 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT SHOWCASING THE COMPANY'S ACHIEVEMENTS AND COMMITMENTS IN GREEN MANAGEMENT, SOCIAL RESPONSIBILITY AND CORPORATE GOVERNANCE. IN THE REPORT, THE COMPANY'S MANAGEMENT EMPHASIZED SEEKING A BALANCE BETWEEN INNOVATIVE DRUG DEVELOPMENT AND SOCIAL RESPONSIBILITY, ENVIRONMENTAL PROTECTION, AND COMMITTED TO LONG-TERM SUSTAINABILITY. The company's efforts to protect the environment include optimizing business operations management processes, reducing waste generation, actively adopting environmentally friendly materials, and taking environmental factors into account during R&D. In addition, the company continuously optimizes its governance structure, ensures smooth and compliant operations, and establishes internal control and compliance systems. In the area of social responsibility, Jun Sengtai cooperates with various NGOs to conduct health education activities and raise public health awareness. Looking ahead, the company will continuously enhance R&D and innovation capabilities, stick to green development, and jointly promote industry development and progress with stakeholders.